12180sek
2,0 %
Date:2026-04-01Time:18:00:00Latest report:Q4-2025List:Mid CapTicker:BIOG B
Market Cap:12 322 msekEnterprise Value:11 520 msekNet Sales:1 538 msekEarnings:332,8 msekEmployees:0ISIN:SE0017769995
Ratios
10-year key figure history for BioGaia turnover, profit, dividend, equity, PE and PB.
Stockprice
Price movement for BioGaia with index and moving average MA50 and MA200.
Stockprice:121,80
MA50:110,57
MA200:104,75
Price/MA200:16,3 %
RSI (14):71,5
Price/MA50:10,2 %
Description
BioGaia is a biotechnology company operating in the pharmaceutical industry and focuses on the development, manufacturing and distribution of probiotics for health and well-being. The company's products are aimed at individuals and healthcare institutions. The business is global with a primary presence in Europe, North America and Asia. BioGaia was founded in 1990 and is headquartered in Stockholm.